NEW YORK, NY – November 20, 2007 – L’Oréal Paris is fully committed to supporting women’s issues and is honored to celebrate its 10-year anniversary as a partner of The Ovarian Cancer Research Fund (OCRF). The partnership has raised over $13 million to fund much-needed research and awareness of this deadly disease. Most recently, L’Oréal Paris hosted “A Night of Hope” which raised $350,000 to benefit OCRF. L’Oréal Paris spokespersons Diane Keaton and Andie MacDowell co-hosted the event with L’Oréal Paris President Carol J. Hamilton and Harper’s Bazaar Editor-in-Chief Glenda Bailey, and they were also joined by L’Oréal Paris spokespersons Eva Longoria, Kerry Washington and Dayle Haddon in Los Angeles on November 7th for the fundraiser.
.jpg)
L’Oréal Paris spokesperson Diane Keaton, L’Oréal Paris President Carol J. Hamilton L’Oréal Paris spokesperson Andie MacDowell, and Harper’s Bazaar Editor-in-Chief Glenda Bailey
All proceeds raised from “A Night of Hope” are donated to OCRF’s research programs. The evening included a cocktail reception and luxury silent auction featuring exceptional photography, fashions and accessories from designers including Chanel, Louis Vuitton, Donna Karan, Bulgari and De Beers. President of L’Oréal Paris, Carol J. Hamilton noted, “This year marks the tenth anniversary of L’Oréal Paris’ support of The Ovarian Cancer Research Fund. I am proud of the fact that L’Oreal is the largest corporate fundraiser in this critical fight against ovarian cancer. Since 1997, we have helped to raise over $13 million to fund life-saving research and to promote awareness building programs that help empower women to make educated choices about their health and well-being.”
“Awareness is a key element in winning the fight against ovarian cancer. There is currently no effective, easy to use method of early detection for ovarian cancer and as a result, many of the cases are diagnosed too late. In addition to raising much needed funds for research programs, L’Oréal Paris has been extremely instrumental in spreading the message that every woman should have knowledge of this disease and its symptoms,” explains Elizabeth Howard, CEO of OCRF.
As part of their deep commitment to women’s issues, L’Oréal Paris has developed several programs to raise awareness and educate women about ovarian cancer as well as honor a cross section of women who are giving back to their communities. L’Oréal Paris’ philanthropic initiatives include:
For more information on any of the programs outlined above, please visit www.lorealcolorofhope.com and www.womenofworth.com
ABOUT L’ORÉAL PARIS
L’Oréal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L’Oréal Paris made a long-term commitment to The Ovarian Cancer Research Fund (OCRF), which continues to build. To date, L’Oréal Paris has helped raise over $13 million dollars on behalf of OCRF with fundraising efforts such as the L’Oréal Legends Gala and L’Oréal’s annual “Color of Hope” jewelry and cosmetic collection. For more information, please visit www.lorealcolorofhope.com.
The L’Oréal Paris Brand Division of L’Oréal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L’Oréal Paris product family includes Preference, Excellence, Natural Match, Féria, and Couleur Experte haircolors; VIVE Pro, Studio Line, and L’Oréal Kids hair care; Dermo-Expertise skin care, including Skin Genesis; Advanced Revitalift, Wrinkle De-Crease, Age Perfect, Men’s Expert, Sublime Slim and Sublime Bronze; and L’Oréal Paris Cosmetics, including Colour Riche Lipcolours, Infallible Never Fail Lipcolour, True Match Makeup, Wear Infinite Eyeshadows, Voluminous, Double Extend, Telescopic, and Volume Shocking mascaras, among many others, and the HIP High Intensity Pigments line.
ABOUT THE OVARIAN CANCER RESEARCH FUND
The Ovarian Cancer Research Fund (OCRF) is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure for ovarian cancer. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 20,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed to funding the best and the brightest of scientific investigators whose work focuses on new tools for detection and better treatment options. To date, OCRF has funded researchers at 40 leading cancer centers nationwide. For more information, go to www.ocrf.org.